Observational studyBMC cancer2021

Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors.

Luisa Maria Griewing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.